Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US set to update PMA (pre-market approval) rule

This article was originally published in Clinica

Executive Summary

The US FDA is considering whether to update the regulation that permits companies to use foreign clinical trials results in premarket approval (PMA) applications. The current position of the agency is that it will accept foreign clinical study data (that is not part of an investigational device exemption) if: they conform to the ethical principles contained in the 1989 version of the Helsinki Declaration; or they provide greater protection for humans, to the laws and regulations of the country in which the research was conducted. .

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT070376

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel